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ABSTRACT
The 5’-cap of spliceosomal small nuclear RNAs,
some small nucleolar RNAs and of telomerase
RNA was found to be hypermethylated in vivo. The
Trimethylguanosine Synthase 1 (TGS1) mediates
this conversion of the 7-methylguanosine-cap to
the 2,2,7-trimethylguanosine (m3G)-cap during mat-
uration of the RNPs. For mammalian UsnRNAs
the generated m
2,2,7G-cap is one part of a bipartite
import signal mediating the transport of the
UsnRNP-core complex into the nucleus. In order to
understand the structural organization of human
TGS1 as well as substrate binding and recognition
we solved the crystal structure of the active TGS1
methyltransferase domain containing both, the min-
imal substrate m
7GTP and the reaction product
S-adenosyl-L-homocysteine (AdoHcy). The methyl-
transferase of human TGS1 harbors the canonical
class 1 methyltransferase fold as well as an unique
N-terminal, a-helical domain of 40 amino acids,
which is essential for m
7G-cap binding and cataly-
sis. The crystal structure of the substrate bound
methyltransferase domain as well as mutagenesis
studies provide insight into the catalytic mechanism
of TGS1.
INTRODUCTION
The m
7G-cap of small nuclear RNAs (snRNAs), small
nucleolar RNAs (snoRNAs) as well as the telomerase
RNA TLC1 is known to be hypermethylated by the
Trimethylguanosine Synthase 1 (TGS1) during maturation
of the respective ribonucleoprotein particles (RNPs).
Especially the biogenesis of the human uridyl-rich
snRNPs U1, U2, U4, U5 and U6, the major components
of the spliceosome, is well characterized (1,2). Except for
U6snRNP, in vertebrates the biogenesis of UsnRNPs
involves a nucleocytoplasmic transport cycle. After tran-
scription by RNA-polymerase II, the snRNAs U1, U2, U4
and U5 acquire an m
7G-cap and are subsequently
exported to the cytoplasm in a cap dependent manner
(3,4). In the cytoplasm seven Sm-proteins (B/B0, D1, D2,
D3, E, F and G) are assembled in a doughnut-like structure
around the highly conserved Sm-site (50-PuA(U)n
GPu-30) of the UsnRNA (5–7). The resulting Sm-core
UsnRNP was shown to be a prerequisite for m
7G-cap
hypermethylation (7,8) by a cap dimethyltransferase,
catalyzing the addition of two methyl groups to the
exocyclic NH2 group of the N7-methylguanine (m
7G)
(7,9,10). The m3G-cap and the Sm-core serve as bipartite
import signal, which mediates the import of the assembled
UsnRNP-core into the nucleus (11–17). The import occurs
by the concerted action of snurportin1 (SPN1), the sur-
vival of motor neuron (SMN)-complex and importinb
(Impb). SPN1 binds the hypermethylated UsnRNA cap-
guanine and the ﬁrst nucleotide of the RNA in a stacked
conformation and bridges the interaction to the import
factor Impb (13,18). After translocation Impb dissociates
from the complex due to the binding of Ran-GTP. A sub-
complex containing at least the assembled UsnRNP and
SPN1, which is bound to the m3G-cap, remains (19) and
its disassembly is not yet understood. The released
UsnRNPs individually associate with speciﬁc sets of pro-
teins, resulting in the particular, mature UsnRNPs U1, U2,
U4 and U5 (20). However, the U6snRNP is generated by a
diﬀerent pathway that does not include such
cytoplasmic maturation steps. In contrast to all other
UsnRNPs it is transcribed by RNA polymerase III
(21–23) and acquires a g-monomethyl-phosphate-cap.
Together with the other UsnRNPs it accumulates subse-
quent to maturation in nuclear (interchromatin) speckles
and in cajal bodies (24,25).
The enzyme responsible for hypermethylation of
the UsnRNA-m
7G-cap in yeast was ﬁrst identiﬁed by
Mouaikel and co-workers in 2002 and it was named
TGS1 in accordance to its function (26). As a bona ﬁde
dimethyltransferase it catalyzes two successive methyl
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(AdoMet) to the exocyclic nitrogen N2 of the cap-guanine,
generating two S-adenosyl-L-homocysteine molecules
(AdoHcy) and the modiﬁed m
2,2,7G( m 3G)-cap (27). The
two Sm-proteins SmB and SmD1 of the UsnRNP-core
bind to TGS1 in yeast and in human cells suggesting an
additional interaction between the dimethyltransferase
and the RNP besides the cap (10,26). Although the yeast
TGS1 (yTGS1) is not essential for cell viability its deletion
results in a cold-sensitive phenotype, as the mutants show
reduced growth at lower temperatures as well as missing
m3G-caps on certain UsnRNAs and snoRNAs (26). As a
consequence of this deletion a splicing defect at restrictive
temperatures is observed and linked to the appearance
of nucleolar retention of U1snRNAs. Furthermore, the
nucleolar morphology is disturbed and the cells show
impairment in ribosome biogenesis. However, it turned
out that it is the TGS1 protein per se, rather than its
catalytic activity that is required for eﬃcient ribosome
synthesis (28).
In contrast to yTGS1, the orthologs from Xenopus
laevis, Drosophila melanogaster, Caenorhabditis elegans,
Mus musculus and Homo sapiens additionally contain
large N-terminal domains.
The human ortholog of yTGS1 was originally desig-
nated PIMT (PRIP-interacting protein with methyltrans-
ferase domain) because of its binding capability to PRIP
(PPAR-interacting protein) and the presence of the
C-terminal methyltransferase domain (29). As shown
recently, the puriﬁed C-terminal methyltransferase
domain of hTGS1 containing the amino acids 576–853 is
able to complement the cold-sensitive phenotype of a yeast
tgs1-strain demonstrating that the human TGS1 methyl-
transferase domain is a true functional ortholog of the
yeast enzyme (30). Hence, H. sapiens PIMT is referred
to as hTGS1 with respect to its function and relatedness
to yTGS1. It was found that hTGS1 is not only able to
bind via its large N-terminus to PRIP, but also to
enhance its action. PRIP was shown to interact with the
peroxisome proliferator-activated receptor (PPAR). This
suggests that the human TGS1 is a component of
the nuclear receptor signal transduction cascade acting
through PRIP, and at least in human cells is involved in
transcriptional regulation (29). Besides that, hTGS1 was
shown to interact with the transcriptional coactivators
CREB-binding protein (CBP), p300 and PPAR-binding
protein (PBP) in vitro and in vivo (31). hTGS1 exists
in two isoforms, a full-length cytoplasmic and an
N-terminally shortened nuclear form, which might be
involved in snoRNP maturation (32,33). In addition it
was found in vivo and in vitro, that the C-terminal part
of the human cap dimethyltransferase interacts directly
with the survival of motor neuron protein (SMNp) (34).
This interaction is greatly impaired in vivo as well as
in vitro by a SMN mutation (SMNEx7) that is most
commonly present in patients who are adversely aﬀected
by the neuromuscular disease spinal muscular atrophy
(SMA). Both proteins are localized in the cytoplasm as
well as in the nuclear cajal bodies, where the assembled
UsnRNPs and snoRNPs reside (34).
Contrary to the comparative mild eﬀects upon dele-
tion of yTGS1, the deletion of its counterpart in
D. melanogaster is lethal to the larvae in the early pupal
stages indicating an essential function in development
(35). The fruit ﬂy ortholog was named drosophila-tat-
like (DTL) because of its capability to bind the TAR-
RNA of the human immunodeﬁciency virus (HIV).
Furthermore, by means of mutagenesis studies it could
be shown that this lethal eﬀect is causally linked to the
observed absence of m3G-caps on UsnRNPs, which is a
direct result of the TGS1-knockdown (35).
The m3G-cap does not solely occur on spliceosomal
UsnRNPs, but also on a subset of small nucleolar
RNAs (snoRNAs). The modiﬁcation of these snoRNAs
such as box C/D (U3) and box H/ACA (snR10/30), which
are, at least in yeast, also hypermethylated by TGS1 is less
well understood (36,37). The cap dimethyltransferase
interacts with speciﬁc proteins of particular snoRNAs
such as Cbf5 and Nop58, thus giving a possibility to dis-
tinguish between UsnRNA and diﬀerent snoRNAs with
respect to their state of methylation (26). As for yeast
UsnRNAs, it was shown for the snoRNAs that they do
not cycle through the cytoplasmic compartment during
maturation (38). Interestingly, it is known that yTGS1 is
localized exclusively in the nucleus and that this organism
lacks the orthologs for important proteins required for
m
7G-cap dependent UsnRNA export (phosphorylated
adapter for RNA export, PHAX) and m3G-dependent
UsnRNP import (SPN1). Therefore it is likely that, in
contrast to vertebrates, the maturation of UsnRNPs and
snoRNPs in Saccharomyces cerevisiae occurs exclusively
in the nucleus. This assumption is further conﬁrmed by
the fact, that the absence of m3G-caps in yeast is not lethal
and instead produces only a cold-sensitive phenotype and
a mild splicing defect (26).
Quite recently, it could be demonstrated that in yeast
the m3G-cap at the 50-end of the telomerase RNA TLC1
results from the catalytic activity of TGS1 as well
(39). TLC1 shares several features with UsnRNAs and
snoRNAs, among them the transcription by RNA-
polymerase II, a high content of uridines, the ability to
bind Sm-proteins and the presence of a 50-m3G-cap.
Deletion of TGS1 in yeast cells inﬂuences the length,
structure and function of telomeres and they show prema-
ture aging (39).
Although there are numerous biochemical data
characterizing TGS1 from H. sapiens, S. cerevisiae,
D. melanogaster, Schizosaccharomyces pombe, Giardia
lamblia and Trypanosoma brucei (27,28,40–43) the three-
dimensional structure of an active form of this enzyme is
unknown so far. However, the crystal structure of a trun-
cated, but catalytically inactive fragment of the human
TGS1 was recently determined. This fragment contains
the canonical methyltransferase domain, which on its
own is not suﬃcient for m
7G-cap hypermethylation (44).
Here we present the 2A ˚ crystal structure of the cataly-
tically active methyltransferase domain of hTGS1. The
results provide insight into the structural organization
and ﬂexibility as well as a detailed view on substrate bind-
ing and recognition by TGS1. Furthermore, on the basis
of the crystal structure and biochemical data including
3866 Nucleic Acids Research, 2009, Vol. 37,No. 12mutagenesis studies, a mechanism for the dimethylation
reaction catalyzed by TGS1 is proposed.
MATERIALS AND METHODS
Protein expression and purification
The human TGS1 fragment comprising the residues
618–853 (hTGS1618–853) was subcloned from pGEX-6P-1
full-length TGS1 (residues 1–853; accession number
Q96RS0) into BamHI/XhoI-sites of pGEX-6P-1 (GE
Healthcare, Germany) and veriﬁed by sequencing. The
GST-fusion constructs were expressed in Escherichia coli
BL21(DE3) (Invitrogen, USA) at 168C in ampicillin con-
taining 2YT-medium, which was supplemented with
2% (w/v) a-D-glucose in order to suppress basal transcrip-
tion. Expression of GST-hTGS1618–853 was induced at
OD600=0.8, adding IPTG to a ﬁnal concentration of
0.5mM. Directly after induction, 2% (v/v) ethanol and
50mM K2HPO4 were added to the growing culture. The
cells were harvested after 18h of expression (5000 g,
20min, 48C) and resuspended in lysis buﬀer containing
50mM Tris/HCl pH 7.5, 500mM NaCl, 2mM EDTA
and 2mM DTT. All subsequent steps were carried out
at 48C unless stated otherwise. Cells were disrupted
using a microﬂuidizer 110S (Microﬂuidics, USA). The
clariﬁed lysate (30000 g, 30min, 48C) was subsequently
loaded onto a GSH-Sepharose column (GE Healthcare,
Germany) equilibrated with lysis buﬀer. Unbound pro-
teins were removed by washing with 2 column volumes
(CV) of lysis buﬀer. In order to eliminate RNA contam-
inations the loaded column was washed with 1CV of a
high salt buﬀer containing 50mM Tris/HCl pH 7.5, 1M
NaCl and 2mM DTT. After re-equilibration in lysis buﬀer
the bound fusion protein was eluted with lysis buﬀer con-
taining additionally 25mM reduced glutathione. For
cleavage the fusion protein (GST-hTGS1618–853) was incu-
bated with PreScission protease (GE Healthcare,
Germany) at 48C overnight in a 1:100 molar ratio of pro-
tease: fusion protein. Further puriﬁcation was achieved
using a Superdex S75 (26/60) gel ﬁltration column
(GE Healthcare, Germany) in a buﬀer containing
20mM Tris/HCl pH 7.5, 200mM NaCl and 2mM DTT.
In order to remove small amounts of remaining GST, the
pooled gel ﬁltration fractions were ﬁnally puriﬁed using a
second GSH-sepharose equilibrated in gel ﬁltration buﬀer.
The pure protein was concentrated to 8mg/ml using viva-
spin concentrators with a molecular weight cut-oﬀ of
10000Da (Sartorius, Germany) and aliquots were frozen
in liquid nitrogen and stored at  808C.
Site-directed mutagenesis
Single amino-acid mutants of hTGS1618–853 (Ser763Ala,
Ser763Asp, Trp766Ala, Asp696Ala, Asp696Asn and
Phe804Lys) were generated from the wild-type clone
using the QuikChange Site-Directed Mutagenesis Kit
(Stratagene, USA) following the manufacturer’s protocol.
All mutations were conﬁrmed by DNA sequencing and
the mutants were expressed and puriﬁed in analogy to
the procedures for the wild-type TGS1-fragment.
HPLC-based activity assay
In order to analyze the activity of the puriﬁed hTGS1
fragment as well as of the described mutants, an HPLC-
based activity assay was applied (44). Total 0.25nmol of
puriﬁed hTGS1618–853 were mixed with 5nmol of the min-
imal substrate m
7GTP (Sigma-Aldrich, Germany) and
20nmoles of the cofactor AdoMet (Sigma-Aldrich,
Germany) in 1  PBS. The mixture with a total volume
of 10ml was incubated at 378C, the reaction was stopped
by the addition of 1ml 1M HClO4 followed by subsequent
incubation on ice for 1min. The solution was neutralized
adding 20ml 2M Na-acetate. Precipitated protein was pel-
leted by centrifugation (16000 g, 10min, 208C) and the
supernatant was loaded onto a reversed phase HPLC-
column (Prontosil C18-AQ, Bischoﬀ Chromatography,
Germany), which was equilibrated in buﬀer A, containing
100mM K2HPO4/KH2PO4 pH 6.5. The substrates and
products of the reaction were eluted from the column
applying a linear gradient from 0% to 60% of buﬀer B,
containing buﬀer A and 50% (v/v) acetonitrile. Commer-
cially available m
7GTP, AdoMet, AdoHcy (Sigma-
Aldrich, Germany) and m
2,2,7
(3)GTP (KEDAR, Poland)
served as reference for column calibration.
Crystallization and structure determination
hTGS1618–853 comprising the C-terminal 235 residues was
crystallized by the vapor diﬀusion method in sitting drop
24-well ChrysChem-plates (Hampton Research, USA)
and in presence of an 8-fold molar excess of both, the
minimal substrate m
7GTP and the reaction product
S-adenosyl-L-homocysteine (AdoHcy). The appropriate
amount of AdoHcy was desiccated, mixed with the protein
solution and incubated for 10min at 208C. Afterwards the
cap-analog m
7GTP was added followed by an additional
incubation for 10min at 208C. One microliter of a reser-
voir solution containing 13–16% PEG 8000 and 0.1M
MES pH 6.2–6.8 was mixed with 1ml of the prepared
protein-substrate solution (4–6mg/ml). Rhombohedral-
shaped single crystals with dimensions of 70 70 
60mm
3 grew at 208C within 2 weeks. Crystals belong
to the space group R3 with the cell dimensions a=b=
156.2A ˚ , c=100.3A ˚ and angles  = =908 and
g=1208. The crystals were ﬂash frozen in liquid nitrogen
after soaking in reservoir solution containing an addi-
tional 15% (v/v) 1,2-propanediol as cryo protectant.
An X-ray diﬀraction dataset of a crystal containing
hTGS1618–853 as well as m
7GTP and AdoHcy was col-
lected at beamline BL14.2 of the electron synchrotron in
Berlin (BESSY). Data were integrated, scaled and reduced
with the HKL2000 suite (HKL Research, USA) and the
structure was solved by means of molecular replacement.
Therefore a starting model was designed, containing the
canonical methyltransferase fold of the previously deter-
mined structure of SeMet-containing inactive hTGS1 (44).
The structure of SeMet-hTGS1 comprising the residues
Pro674-Arg848 served as search model in PHASER (45),
which placed three molecules in the asymmetric unit.
Missing residues, as well as 415 water molecules were
added manually in COOT (46) and the structure was
reﬁned using REFMAC5 (47) to a reasonable Rwork of
Nucleic Acids Research, 2009,Vol.37, No. 12 386718.0% and a Rfree-value of 21.3%. In the ﬁnal model,
92.8% of the residues are located within the most
favoured regions and 7.2% in the additionally allowed
ones, whereas no residues lie in the generously allowed
or disallowed regions of the Ramachandran plot
(see Table 1). Figures were generated using PyMOL
[DeLano, W.L. The PyMOL Molecular Graphics System
(2002), DeLanoScientiﬁc, USA].
RESULTS
The globular core of yTGS1 (aa 58–266) was predicted to
represent the catalytic domain, which corresponds to the
C-terminal residues 653–845 in the human TGS1 (48)
(sequence alignment in Supplementary Data). Recently,
the crystal structure of this canonical methyltransferase
domain of human TGS1 (aa 653–853) was solved, but
this domain lacks catalytic activity suggesting an incom-
plete cap binding pocket (44). Interestingly, a fragment
containing only 17 additional amino acids N-terminally
and therefore comprising the residues 636–853 gains cat-
alytic activity (44). Since all attempts to crystallize the
active TGS1636–853 failed, several further elongated frag-
ments of hTGS1 were tested in crystallization. Finally, the
crystallization of a fragment starting at residue 618
(hTGS1618–853) in the presence of substrate-analogs
succeeded.
Purification and characterization of hTGS1618–853
hTGS1618–853 was cloned and puriﬁed as described in
‘Materials and Methods’ section. An HPLC-based activity
assay was applied to determine the catalytic activity of this
hTGS1 fragment (Figure 1). After the incubation of pur-
iﬁed hTGS1618–853 in the presence of m
7GTP and
AdoMet, their signiﬁcant decrease and conversely increas-
ing amounts of reaction products m
2,2,7GTP and AdoHcy
indicate the catalytic activity of the analyzed fragment
(Figure 1B). The additional peak, for which no commer-
cially available standard exists, elutes at 8.5ml and is most
likely the reaction intermediate m
2,7GTP that has pre-
viously been reported (27,30,42).
Overall structure of the active hTGS1
methyltransferase domain
The active fragment (hTGS1618–853) was crystallized in the
presence of m
7GTP and S-adenosyl-L-homocysteine
(AdoHcy), the crystal structure was solved by means of
molecular replacement and reﬁned at a resolution of 2.0A ˚ .
The statistics of X-ray diﬀraction data and structure
reﬁnement are summarized in Table 1. Crystals belong
to the space group R3 with cell dimensions of a=b=
156.2A ˚ , c=100.3A ˚ and  = =908 and g=1208, con-
taining three TGS1 monomers in the asymmetric unit.
Residues 634–844 of monomer 1 are well deﬁned in the
electron density map, whereas for monomers 2 and 3 only
the residues 637–847 and 641–847 could be placed.
All three monomers superpose well with root mean
square deviations of 0.47A ˚ , 0.60A ˚ and 0.28A ˚ for all
three possible combinations (molecule 1/2, 2/3 and 1/3)
and with respect to all common Ca atoms. Due to the
high similarity of the three monomers only the structure
of monomer 1 is discussed hereafter. One monomer con-
sists of 11 a-helices and seven b-strands (Figure 2). It is
divided into the core domain (residues Glu675-Asp844)
forming the classical class I methyltransferase fold
(green part) and an a-helical N-terminal extension
(NTE) encompassing the residues Leu634-Ser671 (yellow
part). Both domains are separated by a short loop com-
prising the three amino acids Val672, Thr673 and Pro674.
The core domain of the monomer consists of a central
seven-stranded b-sheet, which is ﬂanked by a-helices on
both sides, leading to the typical aba sandwich and resem-
bles the structure of the classical Rossmann-fold AdoMet-
dependent methyltransferase superfamily. This fold is
generally referred to as a/b twist with the ﬁrst strand
located in the middle of the b-sheet whereupon the follow-
ing strands are placed consecutively outward to one edge.
Thereafter, the chain returns to the middle of the b-sheet
and continues out to the other edge. Thus, the b-sheet has
a b6"b7#b5"b4"b1"b2"b3" topology with six strands
Table 1. Statistics of the data set of hTGS1 methyltransferase domain
(aa 618–853) bound to m
7GTP and AdoHcy
Crystal hTGS1618–853+m
7GTP+AdoHcy
Data collection
Space group R3
Cell dimensions
a, b, c (A ˚ ) 156.2, 156.2, 100.3
 ,  , g (8) 90, 90, 120
Wavelength (A ˚ ) 0.9184
X-ray source BL14.2, BESSY (Berlin)
Resolution range (A ˚ ) 30.00–2.00 (2.07–2.00)
Number of reﬂections 61489
Completeness (%) 99.8 (100.0)
Rmerge
a (%) 5.4 (35.9)
Average I/s 16.5 (2.6)
Redundancy 2.4 (2.4)
Mosaicity (8) 0.20
Reﬁnement
Resolution (A ˚ ) 30.0–2.00
Molecules per AU 3
Number of atoms
Protein 4973
Ligand 202
Waters 415
Rwork
b (%) 18.0
Rfree
c (%) 21.3
Figure of merit 0.86
Average B factors (A ˚ 2)
Protein 33.0
Ligand 32.9
Waters 38.9
RMS deviations
Bond lengths (A ˚ ) 0.005
Bond angles (8) 0.914
Ramachandran statistics (%)
Most 92.8
Allowed 7.2
Generous 0.0
Disallowed 0.0
Values in parentheses indicate the speciﬁc values in the particular high-
est resolution shell.
aRmerge=
P
hkl
P
i|Ii(hkl)   <Ii(hkl)>|/
P
hkl
P
iIi<(hkl)>, where the sum
i is over all separate measurements of the unique reﬂection hkl.
bRwork=
P
hkl||Fobs|   |Fcalc||/
P
hkl|Fobs|.
cRfree as Rwork, but summed over a 5% test set of reﬂections.
3868 Nucleic Acids Research, 2009, Vol. 37,No. 12Figure 2. Overall structure of the human TGS1 methyltransferase domain. The crystallized methyltransferase domain comprising the residues
Leu634-Asp844 is shown in cartoon representation and the bound substrate-analogs S-adenosyl-L-homocysteine (AdoHcy, red) and m
7GTP (blue)
are depicted in ball-and-stick mode. The methyltransferase core (Glu675-Asp844) is colored in light green, whereas the N-terminal, a-helical exten-
sion (NTE; Leu634-Ser671) is shown in yellow. Both views are rotated by 658 with respect to each other around the indicated rotation axis. The
secondary structure elements are labeled. The upper panel shows a surface representation of the active site cleft highlighting the enclosure of both
ligands by the enzyme.
Figure 1. HPLC-based methyltransferase assay showing the catalytic activity of the crystallized hTGS1618–853.( A) Chromatogram of the control
reaction containing the substrates but no puriﬁed human hTGS1618–853 and (B) chromatogram after 10min of incubation at 378C including the
puriﬁed enzyme. The elution volume is plotted against the absorption at 260nm (left y-axis) and the acetonitrile concentration (right y-axis),
respectively. The corresponding peaks are labeled and the putative reaction intermediate m
2,7GTP is marked by an asterisk.
Nucleic Acids Research, 2009,Vol.37, No. 12 3869in a parallel and the last one (b-strand 7) in an anti-
parallel orientation but positioned in between b-strand 5
and 6 (Figure 2). The b-sheet is twisted, thus the two out-
ermost strands lie in an almost perpendicular orienta-
tion with respect to each other. Between two consecutive
b-strands one or more a-helices build a right-handed
crossover connection. Thus altogether three a-helices
(a5, a6, a7) pack against one side of the b-sheet and
another three helices (a8, a10, a11) on the opposing
side. The a-helices adjacent to the b-sheet are oriented
almost parallel to the strands, following the rotation
impaired by this b-sheet. Using this conserved methyl-
transferase core as search model, the program DALI
(49) found nearly 600 methyltransferases in the protein
databank (PDB) with Z-scores greater than 12, indicating
a closely related fold as discussed below.
The remaining four N-terminal a-helices of the
structure (a1, a2, a3, a4) form a separate overall glob-
ular subdomain (Figure 2, yellow part) with a small
hydrophobic core. This small NTE packs against the
core domain (Figure 2) and is involved in binding and
recognition of both ligands. Interestingly, the residues
Pro769 and Phe670 as well as Pro765 and Glu667 are
in close proximity to each other and hence close the bind-
ing clefts on the top over both substrates as shown in
the surface representation of Figure 2. A DALI-search
using the NTE (aa 634–674) revealed that there are no
structural related proteins or domains present in the
protein data bank (PDB).
Substrate binding sites
The methyltransferase domain of human TGS1 harbors
both, m
7GTP and AdoHcy bound in a pocket and they
are held in close proximity to each other by an intricate
pattern of hydrogen bonds. Either substrate is well deﬁned
in the |Fo| |Fc| electron density omit map as shown in
Figure 3A.
Figure 3. Binding of the minimal substrate 7-methylguanosine-triphosphate (m
7GTP) and the cofactor-analog S-adenosyl-L-homocysteine (AdoHcy)
by hTGS1618–853.( A) Overall binding of m
7GTP and AdoHcy (ball-and-stick mode) and relative orientation of the substrates to each other. The
substrate molecules are surrounded by a |Fo| |Fc| electron density omit map contoured at 2.9s (m
7GTP and AdoHcy were omitted). The helices
a1–a4 were removed in this view for clarity reasons. (B) Detailed view of the binding-pockets for m
7GTP and (C) for AdoHcy. Protein residues
involved in binding are labeled and drawn in stick mode (yellow) whereas the substrate-analogs are shown in ball-and-stick representation.
Interactions of protein residues with water molecules (light blue) or substrate atoms (e.g. hydrogen bonds) are indicated by dashed lines. Amino
acids participating in the binding of both ligands are marked by an asterisk.
3870 Nucleic Acids Research, 2009, Vol. 37,No. 12The binding site for AdoHcy is mainly built up by resi-
dues belonging to the loops connecting b-strand 1 with
a-helix 6, b-strand 2 with a-helix 7 and b-strand 3 with
a-helix 8, respectively (Figures 2, 3A and C). The loop
joining the methyltransferase core and the a-helix 4 of
the NTE, as well as residues from the helix itself make
additional contacts to AdoHcy. The adenine-moiety of
AdoHcy is directly bound between the two side chains
of Phe698 and Ile720 generating a tight hydrophobic inter-
action (Figure 3C). Furthermore, N6 of this adenine forms
a hydrogen bond with Asp747 and a water molecule,
respectively. The ribose of AdoHcy adopts a C10-exo con-
formation in the crystal structure and its hydroxyls are
bound by two hydrogen bonds each. One hydrogen
bond is formed from both hydroxyls to each of the two
oxygen atoms of Asp719. The other hydrogen bonds are
mediated by two water molecules, while the water bound
to the 20-OH is further coordinated by Glu667. The homo-
cysteine-moiety of AdoHcy, more precisely the amino and
the carboxyl group, are also bound by an extended net-
work of hydrogen bonds to Ser671, Thr673, Asp696,
Cys699, Val701, Gly703, Asn704, Thr705 and Ser763,
respectively (Figure 3C). Three water molecules addition-
ally contribute to this interaction. Within this array of
interactions, the AdoHcy is tightly bound in its binding
pocket and suggests that the site of the methyl group pres-
ent in AdoMet is oriented towards the N2 of the bound
cap-guanine. The distance between the AdoHcy-sulfur
and the methyl group acceptor N2 of the cap-guanine
averages 4A ˚ , representing an ideal spacing for a nucleo-
philic attack of N2 on the AdoMet-methyl group.
The cap-binding pocket is located next to the AdoHcy
binding site and in contrast to AdoHcy, the m
7GTP-ribose
adopts a clear 20-endo conformation (Figure 3A and B).
The guanine of m
7GTP, which is located next to the
homocysteine-moiety of AdoHcy, is perfectly stacked on
Trp766. Both aromatic rings are oriented almost coplanar
with a distance of 3.2A ˚ leading to a tight  –  interaction
between them (Figure 3B). This base stacking is further
stabilized by a cation–  interaction, due to the net positive
electric charge of the guanine caused by the methylation of
N7. The side chain of Trp766 is ﬁxed by the side chain
of Pro806 leading to a higher rigidity of its aromatic side
chain (data not shown). On the opposing side of the
m
7guanine the polar side chain of Ser671 limits the bind-
ing pocket. Further important contacts between the pro-
tein and the cap-analog involve all three phosphates a, b
and g, as well as the guanine nitrogens N2, N1 and the
oxygen O6, generating the speciﬁcity for a guanine base.
The carbonyl oxygen of Pro764 forms hydrogen bonds
with N1 and N2, while the latter is further coordinated
by a water molecule and the main chain carbonyl of
Ser763. The O6 of m
7GTP is bound by the main chain
amide of the stacking Trp766 as well as by two water
molecules, which are held in position by a complex inter-
action network with Ser671, Gly767 and Gly768.
Moreover, the g-phosphate of the cap-analog is bound
by Lys646 and a water molecule, whereas the b-phosphate
is ﬁxed by the same lysine residue and two addi-
tional interactions to atoms NH1 and NH2 of Arg807
(Figure 3B). The most pronounced interactions occur
with the a-phosphate, which is positioned by Tyr771,
Arg807 and two water molecules, respectively.
Besides the two substrate-analogs, two molecules of
the cryo protectant 1,2-propanediol are bound to the
cap-analog m
7GTP and to the surface of the protein,
respectively (data not shown). The ﬁrst propylene glycol
molecule binds via its hydroxyls to the b-phosphate and
the 30OH of the cap-nucleotide of all three molecules,
whereas the second one is bound on the surface of the
protein molecules 1 and 3 involving the residues Asp739
and Ala738, respectively. However, the interaction of
1,2-propanediol with m
7GTP does not interfere with its
interaction to the protein. The two hydroxyls of propylene
glycol forming the hydrogen bonds are expected to be
replaced by water molecules in an aqueous solution lack-
ing the cryo protectant.
Mutagenesis studies
The impact of residues involved in substrate binding was
analyzed for the crystallized fragment (hTGS1618–853).
The residues Trp766, Ser763, Asp696 and Phe804, which
participate in substrate binding or facilitate catalysis, were
mutated and their inﬂuence on catalytic activity was mea-
sured using the HPLC-based activity assay. The eﬀect of
individual residues on catalytic activity of TGS1 is sum-
marized in Table 2. For this purpose, the area of the
m
7GTP-peak after 20min of incubation with the accor-
dant mutant protein was compared to the corresponding
peak areas of a control reaction without enzyme (0% activ-
ity) and in the presence of the wild type enzyme (100%
activity), respectively.
As expected, substitution of the stacking tryptophan
by alanine (Trp766Ala) results in a complete loss of
methyltransferase activity (<1% of wild-type activity).
This observation underlines the ultimate importance of
the aromatic indole ring being the exclusive cation– 
and  –  stacking partner for the m
7G-cap in the binding
pocket. Further on, replacement of serine 763, which was
postulated to be a key residue in catalysis by alanine
(Ser763Ala) roughly reduces the catalytic activity of the
enzyme by a factor of ﬁve. A mutant containing an aspar-
tate instead of serine 763 (Ser763Asp), as present in some
other methyltransferases and the G. lamblia TGS2, shows
almost wild-type activity conﬁrming the hypothesis that a
proton acceptor in this position enforces catalysis. When
we tried to purify the mutant containing an alanine
instead of aspartate 696 (Asp696Ala), the protein imme-
diately precipitated subsequent to elution from the ﬁrst
Table 2. Eﬀect of selected amino acid mutations on
catalytic activity of hTGS1618–853
Mutation Activity
wt (hTGS1618–853) 100%
W766A <1%
S763A 18%
S763D 97%
D696A n/a
D696N n/a
F804A n/a
Nucleic Acids Research, 2009,Vol.37, No. 12 3871GSH-sepharose-aﬃnity column. Nevertheless, in order to
test the eﬀect of the lacking carboxyl group on the side
chain of Asp696 without losing the structural integrity, we
generated the more conservative mutant Asp696Asn.
Surprisingly, this mutation showed the same eﬀect on pro-
tein stability as the exchange against alanine, revealing the
strict requirement of aspartate 696. The obvious structural
importance therefore prevents the detailed analysis of the
catalytic impact of Asp696. The analysis of replacement of
Phe804 by an alanine or by a positively charged residue
(e.g. lysine) was impeded by a related problem. Phe804
in combination with other residues is thought to form a
hydrophobic pocket harboring the ﬁrst transferred methyl
group and therefore supporting the second methylation
reaction (see below). However, replacement of this residue
results in a signiﬁcant reduction of bacterial cell growth
during expression and mostly insoluble protein after cell
lysis.
Potential protein and RNA interaction sites
In order to ﬁnd potential binding sites of the hTGS1-
methyltransferase domain for RNA nucleotides adjacent
to the 50-cap as well as for interacting proteins of the cog-
nate RNPs, an electrostatic surface potential of the pro-
tein was calculated (Figure 4). The front view (left hand
side) shows TGS1 in the same orientation as in Figure 2
(left-hand side) with the bound substrates. In the side view
(middle) basic patches in close proximity to the m
7G-cap-
binding pocket indicate the binding site for further RNA
nucleotides. In fact, the ﬁrst some ten nucleotides of
the U1snRNP are accessible for interaction partners as
demonstrated by RNAse H digestion experiments (13).
The back view (right-hand side) reveals acidic patches of
hTGS1 methyltransferase domain, which are likely to bind
the positively charged C-terminal tails of Sm-proteins B
and D1. The interaction of RNP speciﬁc proteins and
TGS1 in human and yeast was investigated in extenso
(26,34,48).
DISCUSSION
The RNA 50-cap dimethyltransferases from diverse organ-
isms have been biochemically characterized, however no
crystal structure of an active enzyme has been available
allowing an investigation of the structure-function rela-
tionship. In the present study we report the crystal struc-
ture of the active C-terminal methyltransferase domain
of human m
7G-cap-speciﬁc dimethyltransferase TGS1
bound to the minimal substrate m
7GTP as well as the
reaction product S-adenosyl-L-homocysteine (AdoHcy).
Recently, it was reported that the canonical and struc-
turally conserved methyltransferase domain of hTGS1 is
not suﬃcient for catalytic activity, but requires 17 addi-
tional residues to gain catalytic activity (44). Figure 5A
shows the superposition of the active (hTGS1618–853) and
inactive (hTGS1653–853) form of the hTGS1 methyltrans-
ferase domain. The structural reason for the loss of func-
tion of the shorter hTGS1 fragment is a signiﬁcant change
in the conformation of the N-terminal extension (NTE),
Figure 5. Superposition of the active (aa 618–853; NTE in blue) and
inactive (aa 653–853; NTE in red; PDB ID 3EGI) hTGS1 methyltrans-
ferase domain (A) and detailed view on the hydrophobic core of the
NTE of the active conformation (B). Hydrophobic residues of the NTE
are drawn in space-ﬁlling spheres to clarify the core. Residues, that are
not present in the inactive structure (Leu634-Arg651) and which con-
tribute to the hydrophobic core are drawn in dark grey and labeled in
white, while amino acids from 652 on are colored in white and labeled
in black.
Figure 4. Charge distribution on the hTGS1 surface. Basic patches are
colored in blue, while acidic ones are depicted in red. The three views
are rotated by 908 with respect to each other. The front view has the
same orientation as the left panel in Figure 2, while the side view shows
the putative binding region for the ongoing UsnRNA backbone (blue
patches). The back view reveals two acidic regions, representing poten-
tial interaction sites for the Sm-proteins B and D1 or other proteins.
3872 Nucleic Acids Research, 2009, Vol. 37,No. 12which forms a small a-helical subdomain in the active
state (blue part in Figure 5), while it contains three
b-strands in the inactive state (red part). The NTE is
essential for m
7G-cap binding and as it completes the sub-
strate binding pocket. Lys646, Tyr647, Glu667, Phe670,
Ser671, Val672 and Thr673 of this NTE are involved in
m
7G-cap binding (Figure 3). The NTE is mainly stabilized
by its hydrophobic core consisting of the residues Ile638,
Leu644, Trp648, Leu654, Phe655, Leu664, Gly668
and Trp669 (Figure 5B). The truncated NTE of
hTGS1653–853 adopts a diﬀerent fold, since important resi-
dues of the hydrophobic core are missing, resulting in the
formation of three b-strands instead of a-helices present in
the NTE of the active form.
m
7G-cap-binding mode
To date several three-dimensional structures of m
7G-cap-
binding proteins are known, clearly deﬁning their binding
characteristics for the positively charged, N7-methylated
guanine of the 50-cap structure. Among them are the
eukaryotic initiation factor 4E (eIF4E) (50) the viral pro-
tein 39 (VP39) (51) and the small subunit of the cap-bind-
ing complex CBP20 (52) all of which show a tight stacking
of the cap-N7-guanine between two aromatic side chains
(eIF4E, Trp56/Trp102; VP39, Tyr22/Phe180; CBP20,
Tyr20/Tyr43) (Figure 6). Diﬀering thereof, the scavenger
decapping enzyme DcpS (53) and the inﬂuenza virus poly-
merase subunit PB2 (54) stack the m
7G-cap only on one
side by an aromate and by a non-aromatic side chain on
the other (DcpS, Trp175/Leu206; PB2, Phe404/His357).
Recently, it was shown that in the poly(A)-speciﬁc ribo-
nuclease (PARN) a second stacking residue is completely
missing and the N7-methylguanine is mainly bound by the
aromate Trp475 (Figure 6) (55–57).
In order to gain insight into the cap binding mode of
TGS1 the structural information of the protein Mj0882
(PDB ID 1DUS), which was shown to be a protein related
to a family comprised of bacterial rRNA methyltrans-
ferases (RsmC/RsmD) was used to generate a homology
model of yTGS1 (48). Based on this homology model of
yTGS1, it was suggested that the m
7G-cap is stacked
between the two side chains of Trp178 and Trp75
(which correspond to Trp766 and Trp669 in hTGS1).
However, this cap binding mode remained questionable,
as mutation of Trp75 in yTGS1 to an alanine did not
decrease catalytic activity (48). Indeed the crystal structure
of hTGS1618–853 reveals that only Trp766 (yTGS1 Trp178)
stacks the m
7G-cap, while Trp669 (yTGS1 Trp75) only
makes a water-mediated contact with the 30OH of
m
7GTP via the main chain carbonyl (Figure 3B).
Moreover, the side chain of Trp669 is part of the hydro-
phobic core of the NTE, interacting for example with
Leu664 and Ile638 (Figure 5B). The common second aro-
matic side chain sandwiching the m
7G-cap is replaced by
the side chain of Ser671 that limits the cap-binding pocket
spatially on the side opposing Trp766, allowing for some
ﬂexibility of the NTE (Figures 3B and 6). The structural
data now explain the mutagenesis studies mentioned
above.
Mutagenesis studies
The functional relevance of residues that are involved in
substrate binding was analyzed by studying several single
amino-acid mutants. As expected, the replacement of the
stacking Trp766 (Trp766Ala) results in a complete loss
of catalytic activity, whereas the exchange of another
putative key residue in the active site, Ser763, has a
milder eﬀect. The mutation Ser763Ala decreases the activ-
ity to 18%. Contrary to our results the yTGS1 mutant
Ser175Ala (corresponding to Ser763 in human TGS1)
showed no defect in activity as shown indirectly by the
immunoprecipitation of cellular RNA (48), while the cor-
responding exchange in the fruit ﬂy TGS1 ortholog (DTL)
was lethal to the larvae (35). The mutant Asp696Ala, as
well as a more conservative mutation to an asparagine
(Asp696Asn) resulted in insoluble and precipitating
hTGS1, demonstrating the importance of this residue to
maintain a structurally stable enzyme and an intact cata-
lytic pocket. In contrast, Hausmann et al. reported the
puriﬁcation of this mutant and its activity to be reduced
to below 1% (30). In this previous study additional six
residues (Phe655, Thr673, Asn704, Asp719, Asn731,
Arg807 and Asn808) predicted to be important for activity
were mutated to alanine and characterized using a radio-
active methylation assay (30). In summary, the results
from this mutational analysis can be explained by the
structure analysis of hTGS1618–853. The residues Thr673
and Asn704 establish water mediated hydrogen bonds to
the reaction product AdoHcy in the structure and their
mutation to alanine reduces the activity to 13% and
5%, respectively. Asp719, which makes contacts to both
ribose hydroxyls and therefore signiﬁcantly contributes to
Figure 6. Comparison of the cap binding pockets of several cap binding proteins. The positively charged, N7-methylated guanine-moiety (light grey)
is stacked in between or ﬂanked by the individual, labeled protein residues (yellow). The interaction of m
7guanine with the eukaryotic initiation
factor 4E (eIF4E; PDB ID 1L8B), the small subunit of the cap binding complex (CBP20; PDB ID 1H2T), the vaccinia virus protein 39 (VP39; PDB
ID 1AV6), the inﬂuenza virus polymerase subunit PB2 (PDB ID 2VQZ), the scavenger decapping enzyme (DcpS; PDB ID 1ST0), hTGS1618–853 and
the poly(A)-speciﬁc ribonuclease (PARN; PDB ID 3CTR) is shown.
Nucleic Acids Research, 2009,Vol.37, No. 12 3873a binding of AdoHcy, reduces the catalytic activity to
<1% when mutated to alanine. Both amines NH1 and
NH2 of the guanidinium group of Arg807 form hydrogen
bonds to the a- and the b-phosphate of the cap-analog,
thus the mutation Arg807Ala results in a decrease of activ-
ity to 8% compared to the wild type protein. Replacement
of Phe655, which is part of the hydrophobic core
(Figure 5B), with alanine reduced the measured activity
to less than 1% indicating its importance in the stabiliza-
tion of the NTE and thus its connection to the methyl-
transferase core. Another important residue Asn731 is
located in a-helix 7 and makes two contacts to the main
chain carbonyl and amine of Lys663, which belongs to the
NTE. The mutation Asn731Ala reduces the activity to 4%
compared to the wild type protein. Located in the cleft
between both domains it contributes signiﬁcantly to the
stability of their interaction and thus promotes the active
conformation of the enzyme. A related function is fulﬁlled
by the side chain Nd of Asn808, which forms two hydro-
gen bonds to the main chain carbonyls of Ala774 (2.8A ˚ )
and Tyr771 (3.2A ˚ ) the latter of which is directly posi-
tioned in a-helix 9. Mutation of this asparagine to an
alanine decreases the TGS1 activity to about 11%. This
region encompassing the residues (Gly767 to Thr773) is
not visible in the inactive structure of the hTGS1653–853,
which does not contain a correctly bound substrate. Thus
the interactions between Asn808 and the mentioned car-
bonyls help to ﬁx this region in a deﬁned conformation
competent to bind the cap-analog m
7GTP.
Catalytic mechanism
Catalysis by most methyltransferases is known to proceed
by an SN2 substitution reaction (58). On the basis of the
presented structural and functional characterization of the
human TGS1 methyltransferase domain in complex with
substrate-analogs the following model for the catalytic
mechanism of dimethylation by TGS1 is proposed. The
exocyclic N2 of the m
7G performs a nucleophilic attack
on the activated methyl group of the AdoMet. The dis-
tance of 4A ˚ between the AdoHcy sulfur and the cap N2
atoms observed in our crystal structure is consistent with
that mechanism (59). In order to increase the nucleophili-
city of the N2 its hybridization state has to be changed
from sp
2 to sp
3. This transition might be stabilized by the
main chain carbonyl oxygens of Ser763 and Pro764, which
are in reasonable distance and a productive orientation
(Figure 7). Such a mechanism was previously proposed
for N6-adenine DNA methyltransferase MTaqI (60).
Accordingly, the carbonyl oxygens of Pro764 and
Ser763, which are both located out of the planar purine
ring pull the hydrogens of N2 out of the conjugated
system. In TGS1 the positive charge of the methylated
guanine leads to an increased electron pull on N2 facilitat-
ing its deprotonation. This generates a lone pair of elec-
trons that is no longer part of the conjugated system
leading to an enhanced nucleophilicity of N2, which is
required to attack the methyl group.
During this process the exocyclic NH2 has to release a
proton which most likely is accepted by a protein residue.
A putative proton acceptor is the hydroxyl group of
Ser763, which is, however, in a distance of 4.2A ˚ .
Interestingly, a diﬀerent rotamer of this side chain
would reduce the distance to 2.5A ˚ , which would allow
the direct proton transfer. In the observed conformation
the serine hydroxyl group forms a hydrogen bond to a
water molecule, which in turn is additionally bound to
the carboxyl group of Asp696 and the main chain carbo-
nyl group of Phe761. Therefore it appears likely that the
proton is transferred via the serine side chain to the water
molecule. However, this role of Ser763 is not essential,
since its mutation to alanine reduces the activity to 18%.
Furthermore, the exchange of Ser763 with an aspartate
residue nearly retains catalytic activity compared to the
wild type enzyme (97%). This mutation is observed in
some other methyltransferases like in the G. lamblia
TGS2 and a mimivirus methyltransferase (mimiTGS),
altering the main catalytic motif from
763SPPW
766 to
DPPW (42,61). In fact, for the tRNA N2, N2-guanosine
dimethyltransferase Trm1 it was postulated that the
negatively charged carboxyl group of the aspartate in
this motif is the general base deprotonating the guanine
N2 (62).
Figure 7. Proposed catalytic mechanism of methyltransfer by hTGS1.
The methylation proceeds by an SN2 substitution reaction. The exo-
cyclic N2-amino group forms hydrogen bonds with the carbonyls
of Ser763 and Pro764 of the motif
763SPPW
766 and the release
of the hydrogen is further promoted by the net positive charge distrib-
uted over the whole methylated purine ring. Once shifted towards the
tetrahedral state (sp
3) the N2 attacks the methyl group. After exchange
of AdoHcy with a new AdoMet molecule the N2 methyl group is
located outside of the ring plane and stabilized by a hydrophobic
pocket formed by Trp766, Pro764 and Phe804. The second methylation
then applies to the same mechanism as the ﬁrst one with an additional
activation of N2 by the methyl group. The proton release is facilitated
further by the side chain of Ser763 connected to a water molecule,
which on its own forms a hydrogen bond with the side chain carboxyl
of Asp696 and the Phe761 carbonyl, respectively.
3874 Nucleic Acids Research, 2009, Vol. 37,No. 12After the ﬁrst methylation the reaction products
AdoHcy and m
2,7G-cap dissociate from the active site,
allowing the binding of two new substrates. The assump-
tion that the dimethylation is not a processive reaction is
supported by fact that S. pombe TGS1 under m
7GDP-
excess conditions converts almost exclusively m
7GDP to
m
2,7GDP. Only when the educt m
7GDP was limiting,
the enzyme converted the reaction intermediate further
to the end product m
2,2,7
(3)GDP in a pulse-chase experi-
ment (27). After binding of the intermediate m
2,7GTP, the
second methylation presumably applies to the same
mechanism. The N2 is activated additionally by the ﬁrst
bound methyl group located outside of the plane of the
guanine ring. This methyl group would ﬁt in an adjacent
hydrophobic pocket formed by Trp766, Pro764 and
Phe804 (data not shown). The activated N2 attacks
the newly bound AdoMet-methyl group, leading to the
second methylation reaction, which results in the fully
modiﬁed m
2,2,7G-cap.
Comparison with structurally and functionally related
methyltransferases
The three-dimensional structures of several other RNA-
modifying methyltransferases targeting exocyclic amino
groups of nucleobases are known. Among them are the
rRNA-adenine dimethyltransferase KsgA (63), the rRNA
guanine methyltransferase RsmC (64) and the tRNA-
guanine-N2 dimethyltransferase Trm1 (62). The methyl-
transferase core domains of KsgA, RsmC, Trm1 and
hTGS1, encompassing the canonical aba sandwich, are
structurally very similar, whereas the remaining parts of
these enzymes diﬀer signiﬁcantly.
RsmC contains two separate methyltransferase
domains, with only the C-terminal one binding the sub-
strate-guanosine and AdoMet in the crystal structure (64).
Unlike hTGS1, RsmC contains the four residues
305NPPF
308 in both the N-terminal and the C-terminal
methyltransferase domains. RsmC binds the guanosine
mainly by its stacking interaction with the aromatic side
chain of Phe308. However, the distance of 4.7A ˚ between
the AdoMet methyl group and the exocyclic target amino
group suggests that the substrates are in a non-productive
orientation.
Interestingly, the Pyrococcus horikoshii Trm1 contains a
C-terminal extension, which is proposed to be involved in
tRNA-binding and composed of six a-helices and six
b-strands forming the three subdomains C1–C3 in addi-
tion to the conserved aba-sandwich. The N-terminus con-
tains two additional b-strands generating a small b-sheet
enclosing a-helix 1, which represents the ﬁrst helix of the
methyltransferase domain and a two b-strand insertion
between a-helix 3 and b-strand 7 elongating the present
b-sheet to nine strands.
The four related methyltransferases KsgA, RsmC,
Trm1 and hTGS1 bind the cofactor AdoMet or its
analog AdoHcy in a structurally conserved binding site,
but the residues that contribute to the binding of AdoMet
are not strictly conserved. The common catalytic motif
of KsgA, RsmC and hTGS1, which has the sequence
1(N/D/S)-
2(P/L)-
3(P)-
4(W/F/Y), is altered in Trm1 as it
lacks the second residue. The ﬁrst residue of this motif is
involved in the activation of the methyl group acceptor,
which is held in position by the two main chain carbonyl
oxygens of the ﬁrst and second residues. The aromatic side
chain of the last motif residue is generally believed to bind
the methyl-acceptor nucleobase by stacking interaction as
experimentally demonstrated for RsmC and hTGS1.
In summary, our structural studies on hTGS1 revealed
the necessity of an unexpected N-terminal and helical
extension required for m
7G-cap binding and catalytic
activity in addition to the canonical methyltransferase
domain.
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